Pfizer
PFE
$29.69
Share price
-1.49%
Change (1 day)
-40.10%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Revenue for Pfizer (PFE)
Revenue in 2023 (TTM): $68.53 B
According to Pfizer's latest financial reports the company's current revenue (TTM) is $68.53 B. In 2022 the company made a revenue of $100.33 B an increase over the years 2021 revenue that were of $81.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pfizer from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $68.53 B | -31.69% |
| 2022 | $100.33 B | 23.12% |
| 2021 | $81.49 B | 71.04% |
| 2020 | $47.64 B | -7.93% |
| 2019 | $51.75 B | -3.53% |
| 2018 | $53.64 B | 2.09% |
| 2017 | $52.54 B | -0.53% |
| 2016 | $52.82 B | 8.13% |
| 2015 | $48.85 B | -1.52% |
| 2014 | $49.60 B | -5.83% |
| 2013 | $52.67 B | -11.48% |
| 2012 | $59.50 B | -11.74% |
| 2011 | $67.42 B | -0.57% |
| 2010 | $67.80 B | 35.59% |
| 2009 | $50.00 B | 3.55% |
| 2008 | $48.29 B | -0.25% |
| 2007 | $48.41 B | -1.76% |
| 2006 | $49.28 B | -3.93% |
| 2005 | $51.29 B | -2.32% |
| 2004 | $52.51 B | 16.21% |
| 2003 | $45.18 B | 39.59% |
| 2002 | $32.37 B | 0.35% |
| 2001 | $32.25 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $91.32 B | 33.24% | 🇺🇸 USA |
 Novartis NVS | $52.32 B | -23.66% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $39.95 B | -41.70% | 🇺🇸 USA |
 Eli Lilly LLY | $32.07 B | -53.20% | 🇺🇸 USA |
 Amgen AMGN | $26.83 B | -60.85% | 🇺🇸 USA |
 Merck MRK | $59.31 B | -13.46% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $44.93 B | -34.44% | 🇺🇸 USA |
 AstraZeneca AZN | $44.99 B | -34.35% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $36.53 B | -46.69% | 🇬🇧 UK |